Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Society for Translational Oncology Awards Pinedo Prize to Dr. Gabriel N. Hortobágyi

June 4, 2011

The Society for Translational Oncology (STO) is honored to award the 2011 Bob Pinedo Cancer Care Prize to Dr. Gabriel N. Hortobágyi, Nellie B. Connally Chair, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center. Dr. Hortobágyi is awarded the prize for his life-long dedication to cancer patients and his pioneering progress in bringing new hope to breast cancer patients.

Durham, NC (PRWEB) June 02, 2011

The Society for Translational Oncology (STO) is honored to award the 2011 Bob Pinedo Cancer Care Prize to Dr. Gabriel N. Hortobágyi, Nellie B. Connally Chair, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center. Dr. Hortobágyi is awarded the prize for his life-long dedication to cancer patients and his pioneering progress in bringing new hope to breast cancer patients.

In honor of his award, Dr. Hortobágyi will deliver the keynote lecture “Towards Individualized Breast Cancer Therapy: Translating Biological Concepts to the Bedside” on Wednesday, September 7, 2011 at the 2nd Annual STO meeting to be hosted in collaboration with the 3rd International Cancer Symposium of the Centre for Cancer Research and Cell Biology, Queen’s University Belfast at the Waterfront Hall in Belfast, Northern Ireland. This lecture will be published in a future issue of STO’s official peer-reviewed journal, The Oncologist.

Dr. Hortobágyi is widely recognized for developing combined modality therapy for previously inoperable breast tumors, improving multidisciplinary treatment for patients with all stages of the disease and conducting clinical trials to develop treatment regimens that have become standard practices for managing breast cancer. A past president of ASCO, he is on the Board of Directors of the Conquer Cancer Foundation and has previously held leadership positions with Susan G. Komen for the Cure and the International Association of Breast Cancer Research. He has been recognized for his groundbreaking research efforts with many awards, including honorary doctorates from 3 leading universities in Italy, Mexico and Argentina. He has published over 1,000 articles in the scientific literature, edited 13 books, contributed more than 140 chapters to textbooks and serves as an editor to over 23 publications. As a Senior Editor for The Oncologist and medical advisory committee member for the Society for Translational Oncology, Dr Hortobágyi has been a major advocate for the discovery and translation of important new treatments in the field of cancer medicine to the practice of global oncology.

As Dr. Patrick G. Johnston, co-chairman of STO said, “Dr Hortobágyi is an outstanding clinician and cancer leader. He has dedicated his career to the improvement of cancer patient treatment across the globe, and his work has led to major improvements in outcomes for breast cancer patients. I am thrilled that his contribution and leadership have been recognized in this way.”

The Pinedo Cancer Care Prize honors Professor H.M. (Bob) Pinedo, founder of the VU University Medical Center (VUmc) Cancer Center Amsterdam (CCA), who weds world-class cancer research with a devotion to his patients and their families. First presented by Medical Knowledge Institute in 2006, The Bob Pinedo Cancer Care Prize has been awarded to five distinguished physician-scientists:

  •     Bruce Chabner, MD ““ Massachusetts General Hospital Cancer Center
  •     Joseph Bertino, MD ““ The Cancer Institute of New Jersey
  •     Bob Löwenberg, MD ““ Erasmus University Medical Centre
  •     Richard O’Reilly, MD ““ Memorial Sloan-Kettering Cancer Center
  •     José Baselga, MD, PhD ““ Massachusetts General Hospital Cancer Center

Nominations for the 2012 Pinedo Prize should be sent to Professor Patrick Johnston, Chairman, Nominating Committee: Pinedo.Prize(at)STO-online(dot)org no later than February 1, 2012. All nominees will be evaluated by an international nominating committee.

About the Society for Translational Oncology

STO is a non-profit, tax exempt association whose mission is to speed the discovery and translation of important new treatments in the field of cancer medicine to the practice of global oncology. STO brings knowledge and strategies for critical new developments in cancer treatment to the practice of the community oncologist. For more information, visit: http://www.sto-online.org.

About The Oncologist

Recognized as a premier peer-reviewed cancer medicine journal, The Oncologist, now in its sixteenth year, is devoted to physicians entrusted with the care of cancer patients. The Oncologist is the official publication of the Society for Translational Oncology. For more information, visit: http://www.theoncologist.com.

About The University of Texas MD Anderson Cancer Center

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world’s most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For seven of the past nine years, including 2010, MD Anderson has ranked No. 1 in cancer care in “America’s Best Hospitals,” a survey published annually in U.S. News & World Report.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/6/prweb8518203.htm


Source: prweb